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Abstract Recent studies have suggested that the innate
immune system is involved in the pathogenesis of pre-
eclampsia. Its pathogenesis involves neutrophil activation
and increased levels of cell-free DNA in the maternal
plasma. Activation of neutrophils has recently been shown
to induce DNA containing neutrophil extracellular traps
(NETs) which trap and kill bacteria. Massive NETs
induction by the placentally derived factors (IL-8 and
placental micro-debris) and their increased presence in
preeclamptic placenta suggest that NETs might be involved
in the pathogenesis of preeclampsia. Therefore, increased
presence of NETs in preeclampsia may play a role in the
deficient placental perfusion associated with this disorder.
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Introduction
Although pregnancy seems a happy symbiosis between
mother and fetus, in reality, this symbiosis is very
complicated. Success of any pregnancy hinges on a mother
embracing her fetus immunologically rather than attacking
it. Why would a mother’s body attack her own fetus? The
reason is very obvious; it only belongs partially to the
mother. Half of the gene pool of the fetus is contributed by
the father; therefore, fetal genes have their own fate. This
strangeness can prompt the mother’s immune system to
counterattack against the fetus. This attack contributes to a
whole spectrum of disorders leading to premature birth that
can be triggered by a condition called preeclampsia
characterized by a rapid elevation in maternal blood
pressure. Pathogenesis of this enigmatic disorder seems to
involve placenta and overt activation of the maternal innate
immune system. In this review, we will focus on the role of
maternal innate system, with emphasis on maternal neu-
trophils, in the pathogenesis of preeclampsia. Moreover, we
will discuss how a recently described novel finding, i.e.,
neutrophils extracellular traps (NETs) formation by activat-
ed neutrophils, play an important role in the pathogenesis of
preeclampsia.
Pathogenesis of preeclampsia
Preeclampsia, a severe disorder of late pregnancy, is
characterized by elevated blood pressure and proteinuria
in previously normotensive pregnant women. It is a leading
cause of fetal and maternal mortality worldwide [1, 2].
Preeclampsia is a multisystem disorder of human pregnancy
that may be explained by two generalized processes
occurring within the maternal and fetal compartments:
vasospasm and endothelial dysfunction. It is widely
accepted that circulating factors, most likely placental in
origin, are responsible for these systemic disturbances. The
precise nature of these factors and the mechanism by which
a placental disorder may induce these pathophysiologic
changes remain unknown. It has been thought to result
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from reduced placental perfusion due to abnormal tropho-
blast differentiation [1, 2]. This placental condition is also
associated with the elevated release of inflammatory
syncytiotrophoblast microvillous membrane microparticles
(STBM) and cytokines, which have been proposed to play a
role in the overt activation of the maternal innate immune
system observed in preeclampsia [3–5].
The STBM are released from the syncytiotrophoblast layer,
which is in direct contact with the maternal blood. Therefore,
STBM are directly released into the intervillous spaces where
they come into the contact with maternal immune cells. It has
been suggested that STBM that are released in preeclampsia
have altered morphologic characteristics, including areas of
syncytial knots attributed to placental hypoxia and areas of
aponecrosis associated with loss of STBM [6]. Increased
levels of STBM have been reported in the uterine venous
and peripheral circulation of women with preeclampsia [7].
It has been shown that STBM have endothelium disrupting
activities and can inhibit the proliferation of endothelial cells
in culture and inhibit endothelial cell-dependent relaxation of
small arteries in vitro [8–10].
Leukocyte activation is increased in preeclampsia com-
pared with normal pregnancies [11, 12]. Therefore, it is
possible that after being released into the maternal circula-
tion, STBM come into contact with maternal neutrophils.
STBM have been shown to activate neutrophils in vitro [13].
Leukocyte interaction with STBM may amplify endothelial
disruption by the release of harmful cytokines and generation
of oxygen-free radicals [14]. Reactive oxygen species
produced by neutrophils may affect vascular tone directly
by contracting smooth muscle tissue and indirectly by
inactivating the endothelium-derived relaxing factor or
reducing the release of prostacyclin [15].
In addition, we and others have previously shown that
preeclampsia is associated with increased transplacental
trafficking of fetal cells [16], as well as elevated concen-
trations of cell-free fetal DNA [17–19] which may occur
before onset of symptoms [20–22]. These studies, however,
also indicated that cell-free DNA levels of maternal origin
were also significantly elevated in preeclampsia and that
these levels correlated well with the severity of the disorder
[18]. While the results concerning fetal cells and cell-free
fetal nucleic acids have been interpreted as further evidence
of an underlying placental dysfunction in preeclampsia,
those concerning the elevated presence of circulatory DNA
of maternal origin have been more difficult to explain, as
the source of this material is unclear [23].
Neutrophils extracellular traps
Recently, Brinkmann et al. [24] described a novel tool
with which neutrophils enhance killing of extracellular
pathogens while minimizing damage to the host cells.
Their data revealed that upon in vitro activation with the
pharmacological agent phorbol myristate acetate, IL-8 or
LPS, neutrophils release granule proteins and chromatin to
form an extracellular fibril matrix, i.e., NETs, through an
active process the molecular mechanism of which remains
to be understood in detail [25]. More recently, Brinkmann
and colleagues have also shown that not only bacteria but
also pathogenic fungi such as Candida albicans induce
neutrophils to form NETs that capture and kill C. albicans
hyphal as well as yeast-form cells. Therefore, they
propose that the NETs could particularly support killing
of microbes that are too large to be phagocytosed
efficiently. A neutrophil can disarm circumvent this
problem by enclosing microbes together with other
neutrophils [25, 26].
Structurally, NETs are composed of nuclear constitu-
ents such as chromatin DNA and histones and granular
peptides and enzymes (e.g., elastase and myeloperox-
idase) that are normally stored in typical neutrophil
granules. DNA is the major structural component of
NETs. The treatment of NETs with DNase results in their
disintegration, suggesting that DNA, which provides the
backbone to the effector proteins, are bound. The NETs
produced by the neutrophils consist of smooth fibers with
a 15–17 nm diameter and globular domains of 25–28 nm
diameter [24].
NETs interact with a variety of different pathogens
Gram-positive and Gram-negative bacteria as well as fungi
and kill them by providing a high local concentration of
antimicrobial proteins such as neutrophil elastase, bacteri-
cidal permeability-increasing protein (BPI), and histones.
NETs have also been shown to play role in the diseases in
vivo. Since Brinkmann et al. [24] originally showed the
occurrence of NETs in spontaneous human appendicitis and
Shigella-induced experimental dysentery in rabbits, NETs
have been found to be abundant at sites of infection.
Recently, two reports have shown the presence of NETs in
the murine models of pneumococcal pneumonia and
fasciitis [27, 28]. Moreover, NETs were also found in
bovine mastitis where neutrophil phagocytosis and oxida-
tive burst have been shown to be hampered by milk fat and
proteins [29].
It has been argued that degrading enzymes of NETs pose
a risk for tissue damage [30]. However, after being released
into the local environment, which is produced by NETs,
these enzymes are less likely to cause damage after
secretion. Nevertheless, NETs might have a deleterious
effect on the host because of the leakage of nucleic acids,
potentially playing a role during the development of
autoimmune diseases like lupus erythematosus, a disease
associated with autoimmune reactions to the host’s own
DNA.
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Preeclampsia and NETs
The discovery of the NETs and their nature to release DNA
in an extracellular form led us to examine whether
placentally derived inflammatory factors can similarly
activate neutrophils to generate NETs and whether the
presence of such NETs was increased in preeclampsia, as
this feature may, hence, link the independent observations
concerning the activation of peripheral neutrophils and the
elevated presence of maternal circulatory DNA during
preeclampsia.
In our in vitro analysis, we examined the capacity of the
placentally derived STBM, produced by various methods,
and STBM-free soluble factors to activate neutrophils and
subsequent NETs generation [31]. Our analysis revealed
that placentally derived STBM and soluble factors effi-
ciently activated neutrophils to generate NETs. Similar to
the findings of Brinkmann et al., these NETs were rich in
DNA, elastase, and histones [31]. Interestingly, we ob-
served that NETs entrapped clusters of the STBM,
suggesting that the NETs not only capture large microor-
ganism such as bacteria (>2 μm) but also ensnare very
small (<200 nm) inflammatory particles such as STBM
(Fig. 1). Among the placentally derived soluble factors, we
could confirm that placentally derived IL-8 was responsible
for the NETs formation [31]. As STBM, and possibly,
placentally-derived IL-8 are released directly by the
syncytiotrophoblast into the maternal circulation in the
Fig. 1 NETs induction by the activated neutrophils. Untreated neutrophils are round and devoid of NETs (a). Upon activation with PMA (b)
STBM (c), and STBM-free villous explants placental conditioned medium (d), neutrophils generated NETs within 30 min of the treatment
Fig. 2 Analysis of the placental
tissue sections for the presence
of NETs. Immunofluorescence
staining of the NETs revealed
their localization within the villi
or adjacent to the syncytiotro-
phoblast in the normal placenta.
The preeclamptic placenta
revealed massive presence of
NETs that are largely localized
within the intervillous space
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intervillous space, we next examined for the presence of
neutrophils NETs in cryosections of placental villous tissue.
The presence of NETs in the placentae, as detected by
combined staining for DNA, histones, and neutrophils-
derived elastase, indicated that their number was quite
small in normal placental tissue compared to preeclamptic
placentae where vast majority of NETs could be observed.
These NETs were also confined to close contact with the
syncytiotrophoblast, possibly at the site of immediate
release of STBM, as this shedding may involve a
budding-off process (Fig. 2) [32].
It is widely accepted that inadequate perfusion of the
placenta by maternal blood is a key feature contributing to
the development and pathogenesis of preeclampsia. In this
regard, the inability of invasive cytotrophoblasts to switch
their repertoire of adhesion molecules to resemble that of
vascular cells [33] results in inadequate invasion and
modification of the maternal spiral arterioles. Consequently,
these uterine arteries remain narrow high resistance vessels,
which cannot adequately bathe the placental villi in an even
slow flow of maternal blood, to meet the even increasing
demands of the fetus for oxygen and nutrients. It has been
proposed that this reduction in placental perfusion can lead
to oxidative stress in the placenta, resulting in the
generation of reactive oxygen species [34]. As enhanced
interactions between vascular tissue and neutrophils have
been demonstrated in ischemic tissues in association with
increased generation of reactive oxygen intermediates [35,
36], it is possible that such a mechanism may operate in
preeclampsia [14], contributing to the generation to the
NETs. In this manner, a cascade, with an endless loop
nature, can be envisaged whereby the initial hypoxic
condition and associated oxidative stress brought about by
inadequate modification of the spiral arteries will lead to
neutrophils activation and NETs formation. The presence of
these NETs will further hinder blood circulation through the
intervillous space, thereby increasing the degree of hypoxia
and associated oxidative stress. In addition, it has been
proposed that hypoxia promotes release of inflammatory
cytokines such IL-6 and IL-8 by placental trophoblast cells
from preeclamptic pregnancies [37]. Consequently, the
increase in the STBM release and IL-8 production by the
ischemic placenta could attract further additional neutro-
phils into the placenta, and their subsequent activation
would lead to further cycles of recruitment and activation.
In this manner, our observations provide a new insight into
the generally accepted view of reduced placenta perfusion
in preeclampsia.
Our data may, however, also bear insight into a currently
less widely accepted new proposal that preeclampsia is not
the result of placental hypoxia but involves periods of
hypoxia and re-oxygenation, which would be associated
with a considerable degree of oxidative stress [34]. This
fluctuation in blood flow would be mediated by the rapid
generation and clearance of NETs, leading to a sudden
influx of oxygen-rich maternal blood into these hypoxic
tissues, thereby contributing conditions of oxidative stress.
As these alternating conditions of hypoxia/re-oxygenation
or oxidative stress are associated with increased apoptosis
and aponecrosis of the villous tissue [6, 38], this would lead
to an increased release of STBM by the ischemic placenta,
thereby inducing the generation of more NETs.
The increased presence of these NETs may also explain
the increased levels of maternal circulatory cell-free DNA
previously observed in preeclampsia [39, 40]. As these
circulatory cell-free DNA levels correlate with disease
severity, this would be indicative of increased NETs
formation, which would fit well with the proposal that
such extracellular entities may play an important role in the
underlying etiology of preeclampsia.
Conclusions
In this review, for the first time, we have described a novel
finding of NETs formation in an inflammatory disease like
preeclampsia. Considering the present notion of preeclamp-
sia pathogenesis, NETs might have a role in the oxidative
stress induction that was observed in its pathogenesis.
Further studies are needed to confirm their presence in
other inflammatory and autoinflammatory diseases where
neutrophil activation has been shown. Understanding the
molecular pathways leading to NETs generation after
neutrophil activation will give us a better insight into the
pathogenesis of inflammatory disorders and might be useful
for the therapeutics.
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